The "Pharmaceutical Headlines" new crown vaccine development competition ranked at most billions of dollars in orders.

(2020/08/13) 7 multinational pharmaceutical companies in the first half of 2020 China's results; intermittent price cuts? Choice questions from Sanming drug collection; four aspects, nine not allowed! A nationwide inspection of public hospitals above level two has begun... (Click on the title to get the original text) "Pharmaceutical 1st Time" 28 COVID-19 candidate vaccine development competition ranking has won billions of dollars in orders at most! Currently, 28 Covid-19 candidate vaccines are being clinically developed or nearing the end, and being the first, or leader, will play a big role in determining the share of the product.
it's not easy to stay ahead of the competition.
Because of the huge global demand for any eligible vaccine, leading vaccine products require clinical data assurance and, at least initially, multiple successes may be required to be able to reach this market.
: The earliest vaccine could be available in October.
Rubik's Cube 7 multinational pharmaceutical companies in the first half of 2020 China's results came out! Multinational pharmaceutical companies in the first half of 2020 financial results have recently been announced, in the COVID-19 and volume procurement under the dual impact of a number of pharmaceutical companies in China's performance is still outstanding.
AstraZeneta continues to hold the top spot across the Chinese market with revenues of nearly $2.7bn, closely followed by Roche and Mercedon.
Sanofi and Pfizer's performance in China was severely affected by volume purchases, both down more than 10 per cent, with the latter down 21 per cent overall, although it did not disclose specific revenue for China.
: Overall, the impact of the outbreak is greater.
the "E Drug Manager" intermittent price reduction? The choice question from Sanming drug collection recently, the industry circulated a Sanming quote news: according to Sanming City Medical Center notice drug dynamic adjustment mechanism, is now part of the catalog to start a price reduction of 10% (prices higher than 200 yuan, relaxed to 5%).
if there is a 10% lower than the catalog (price is higher than 200 yuan, relax to 5%) can be compared with the varieties in the catalog, the final price is low into the catalog.
the headline bacteria: one into the three ming deep like the sea.
health sector four aspects, nine not allowed! On August 10, the Liaoning Provincial Health and Health Commission issued the "Programme for the Implementation of the Inspection of Large Hospitals in Liaoning Province" (hereinafter referred to as the "Programme"), calling for a new round of large-scale hospital inspection work and a comprehensive inspection of public hospitals above level 2 in the province.
focus on four aspects, including public hospital party building, industry style construction, operation management and Chinese medicine hospital characteristics.
headlines: Medical style construction hard work.
"Mi Net" 20 products more than 1 billion "unbanned" China Resources, Jichuan exclusive products in the 2019 edition of the National Health Insurance Catalog released explicitly mentioned that the original provincial drug catalog in accordance with the provisions of the increase in Class B drugs, should be gradually digested within 3 years ... News out, the industry earthquake, and then the provinces have issued "clearing back" rules, in addition to the first batch of national key monitoring varieties have been "powerless to return to the sky", other large varieties in a number of provincial directories are worried, waiting for the "apocalyptith."
: Fish and bear palms can't be both.
VBL Gene Therapy Ovarian Cancer Show Prospects Today Israeli biotech company VBL announced that its gene therapy VB-111 (ofranergene obadenovec) shows some prospects in the second scheduled midterm analysis of a phase III clinical ovarian cancer, and the DSMC expert group recommended that the trial continue.
the trial is expected to recruit 400 patients with ovarian cancer after progressing with the use of platinum drugs to compare the total survival of the single use of yew alcohol/VB-111 with yew alcohol.
: It's only possible in industries that God doesn't participate in.
.